Tag: equity
-
Organ Transplant Start-Up Gains $38M in Early Funds
A one year-old company applying genome editing to make animal organs fit for human transplantation is raising $38 million its first venture funding round.
-
Medical Robotics Company Crowdfunding IPO
A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million.
-
Cancer Blood Test Company Raises $65M in Early Funds
Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing.
-
Duchenne Gene-Editing Company Launched, Raising $5M
A biotechnology start-up is applying a process for editing-out disease-causing mutations to correct the inherited disorder Duchenne muscular dystrophy.
-
Tissue Regeneration Start-Up Gains $33M in Early Funds
A new enterprise founded by researchers at Stanford University aims to discover and develop drugs that repair and regenerate tissue from stem cells.
-
Ford Investing $1B in Artificial Intelligence Start-Up
Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles.
-
Biotechs License Solid Tumor Therapy in $2.1B Deal
Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs.
-
Protein Drug Discovery Company Launches, Gains $50M
A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins.
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Allergy Immunotherapy Firm Raises $2M in Early Funds
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round.